201 related articles for article (PubMed ID: 28510792)
1. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin Expressing Neuroendocrine Tumors of the Pancreas: An Underrecognized Entity.
Celli R; Tang LH; Cai G; Freedman-Weiss M; Colunga M; Salem RR; Majumdar S; Jain D
Pancreas; 2019 Jan; 48(1):55-59. PubMed ID: 30451800
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatic proinsulinoma].
Kriger AG; Berelavichus SV; Gorin DS; Panteleev VI; Demidova VS; Davydenko PI; Varava AB; Kaldarov AR
Khirurgiia (Mosk); 2021; (3):5-10. PubMed ID: 33710820
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell adenomas without hyperinsulinemia with use of highly specific insulin radioimmunoassays: case report and review of literature.
Gómez-Pérez FJ; Cuevas-Ramos D; Valdés PA; Aguilar-Salinas CA; Mehta R; Rull JA
Endocr Pract; 2010; 16(4):660-3. PubMed ID: 20439243
[TBL] [Abstract][Full Text] [Related]
5. Multiple proinsulin-secreting tumors of the pancreas treated by laparoscopic distal pancreatectomy and splenectomy.
Clark G; Sadur C; Puligandla B
World J Surg; 2009 Mar; 33(3):397-9. PubMed ID: 18949512
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Adult-Onset Diffuse β-Cell Nesidioblastosis and Pancreatic Neuroendocrine Tumor: A Case Report and Review of the Literature.
Orujov M; Lai KK; Forse CL
Int J Surg Pathol; 2019 Dec; 27(8):912-918. PubMed ID: 31244364
[TBL] [Abstract][Full Text] [Related]
7. Proinsulin-secreting neuroendocrine tumor of the pancreas.
Piovesan A; Pia A; Visconti G; Terzolo M; Leone A; Magro G; Cesario F; Borretta G
J Endocrinol Invest; 2003 Aug; 26(8):758-61. PubMed ID: 14669832
[TBL] [Abstract][Full Text] [Related]
8. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series.
Yu R; Nissen NN; Hendifar A; Tang L; Song YL; Chen YJ; Fan X
Pancreas; 2017 Jan; 46(1):48-56. PubMed ID: 27984486
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
Zhang C; Jin J; Xie J; Ye L; Su T; Jiang L; Zhou W; Jiang Y; Wu L; Wang T; Zhong X; Ning G; Shen B; Wang W
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785672
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature.
Gutelius BJ; Korytkowski MT; Carty SE; Hamad GG
Am Surg; 2007 May; 73(5):520-4. PubMed ID: 17521012
[TBL] [Abstract][Full Text] [Related]
11. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia.
Tarris G; Rouland A; Guillen K; Loffroy R; Lariotte AC; Rat P; Bouillet B; Andrianiaina H; Petit JM; Martin L
Front Endocrinol (Lausanne); 2023; 14():1125772. PubMed ID: 37234805
[TBL] [Abstract][Full Text] [Related]
14. [Hormone inactive neuroendocrine tumors of the pancreas].
Schwab M; Knoll MR; Jentschura D; Hagmüller E
Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.
Pérez-Pevida B; Idoate MÁ; Fernández-Landázuri S; Varo N; Escalada J
Endocr Pathol; 2016 Mar; 27(1):50-4. PubMed ID: 26801953
[TBL] [Abstract][Full Text] [Related]
16. [Rare tumors of the pancreas].
Hohmann U; Schramm H
Zentralbl Chir; 2003 May; 128(5):429-33. PubMed ID: 12813644
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of proinsulin processing in functioning insulinomas: clinical implications.
Wiesli P; Perren A; Saremaslani P; Pfammatter T; Spinas GA; Schmid C
Clin Endocrinol (Oxf); 2004 Oct; 61(4):424-30. PubMed ID: 15473873
[TBL] [Abstract][Full Text] [Related]
18. Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm.
Mirkin KA; Hollenbeak CS; Wong J
J Surg Res; 2017 May; 211():206-214. PubMed ID: 28501118
[TBL] [Abstract][Full Text] [Related]
19. PROINSULIN-PREDOMINANT PANCREATIC NEUROENDOCRINE TUMOR-INDUCED HYPOGLYCEMIA AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY.
Edwards K; de La Portilla L; Mirza FS; Luthra P
AACE Clin Case Rep; 2019; 5(6):e339-e343. PubMed ID: 31967066
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
